Accelerating cell & gene therapy workflows with next-generation analytical tools

Cell & Gene Therapy Insights 2022; 8(3), 463–473

DOI: 10.18609/cgti.2022.066

Published: 21 April 2022
Innovator Insight
Chris Heger

Modern medicines call for modern technologies. Revolutionary cell and gene therapies offer significant promise to treat life-threatening diseases. However, getting therapies to market quickly and efficiently requires accurate testing of critical quality attributes, including accurate viral vector analysis and cell characterization. This article discusses how a variety of innovative analytical tools can aid in the automation and scalability needed on the cell and gene therapy road to discovery, including rapid and accurate analysis of cells, molecules, and contaminants, along with consistent, high-quality data across project phases. These next-generation analytical solutions are also assessed for the ease with which they fit into current workflows and their adaptability to changing needs.